Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Obesity 8Overweight 3Obesity-Related Malignant Neoplasm 3Endometrial Neoplasms 3Breast Neoplasms 3Motor Activity 2Head and Neck Neoplasms 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Sedentary Behavior 1Sarcoma 1Rectal Neoplasms 1Psychological Well-Being 1Prostatic Neoplasms 1Pharyngeal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Mucositis 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Inflammation 1Hodgkin Disease 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Topiramate 1Tirzepatide 1Tablets 1Specimen Handling 1Qsymia 1Pregabalin 1Phentermine 1Omeprazole 1Nutrition Assessment 1Naltrexone 1Methods 1Liraglutide 1Ketorolac 1Glucagon-Like Peptide-1 Receptor 1Exercise 1Endurance Training 1Diethylpropion 1Diet 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Methods × Other × Clear all
NCT05113485 2022-04-11

UCLA Breast Cancer Survivor Health Promotion Research Study

University of California, Los Angeles

Phase NA Unknown
30 enrolled
BreastOther

Breast Neoplasms, Inflammation, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡